Comparison of the 2021 EUGOGO guidelines and the 2022 ATA/ETA consensus statement for the management of Graves' orbitopathy. [PDF]
Bartalena L +4 more
europepmc +1 more source
Positive Relationships between Intraocular Pressure and Thyroid Function in Graves' Ophthalmopathy: A Three-Aspect Evidence Analysis. [PDF]
Zhang W, Zhang F, Zhu Z, Cao J, Xiong W.
europepmc +1 more source
Introduction of the Ex/AxI ratio for optimized assessment of exophthalmos based on bulbar position parameters examined in a population-based MRI study. [PDF]
Lüdtke L +7 more
europepmc +1 more source
Chronic thyrotoxic myopathy in an 81-year-old man with Graves disease. [PDF]
Nishizawa T, Ueda T.
europepmc +1 more source
Retinal Microvascular and Orbital Structural Alterations in Thyroid Eye Disease. [PDF]
Jelušić V +8 more
europepmc +1 more source
A Pediatric Case of Neurodevelopmental Delay with a Familial <i>H4C11</i> Variant: Clinical Course and Diagnostic Challenges. [PDF]
Tudorache E +4 more
europepmc +1 more source
Baseline selenium is associated with response to intravenous Methylprednisolone with selenium supplementation for thyroid eye disease in a selenium-sufficient area. [PDF]
Sung SM, Lee DC.
europepmc +1 more source
A <i>de novo</i> pathogenic variant in <i>TSHR</i> expanding the phenotype of persistent sporadic congenital non-autoimmune hyperthyroidism: a case report and literature review. [PDF]
Xu W, Liu X.
europepmc +1 more source
Is there a role of radiotherapy for steroid-resistant thyroid eye disease? [PDF]
Noh JM.
europepmc +1 more source

